Viewing Study NCT02960204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-03-14 @ 4:05 AM
Study NCT ID: NCT02960204
Status: COMPLETED
Last Update Posted: 2022-02-11
First Post: 2016-07-29
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Sponsor: Histogen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cirrhosis View
None Portal Hypertension View
None Non-alcoholic Steatohepatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cirrhosis View
None Portal Hypertension View
None Non-alcoholic Steatohepatitis View
None Liver cirrhosis View